Title : miR-129-5p inhibits gemcitabine resistance and promotes cell apoptosis of bladder cancer cells by targeting Wnt5a.

Pub. Date : 2018 Oct

PMID : 30117016






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 miR-129-5p inhibits gemcitabine resistance and promotes cell apoptosis of bladder cancer cells by targeting Wnt5a. gemcitabine microRNA 1295a Homo sapiens
2 This study was aimed to investigate the potential role of miR-129-5p in the development of gemcitabine resistance in bladder cancer cells and its underlying mechanism. gemcitabine microRNA 1295a Homo sapiens
3 RESULTS: We found that down-regulated miR-129-5p level contributed to gemcitabine resistance in bladder cancer cells and tissues. gemcitabine microRNA 1295a Homo sapiens
4 We also observed restoration of miR-129-5p could significantly increase cell sensitivity to gemcitabine and promote cell apoptosis. gemcitabine microRNA 1295a Homo sapiens
5 Mechanism analysis revealed that Wnt5a is a direct target gene of miR-129-5p and knock-down of Wnt5a reversed gemcitabine resistance. gemcitabine microRNA 1295a Homo sapiens
6 CONCLUSIONS: Taken together, our findings indicate that miR-129-5p and Wnt5a may be novel therapeutic targets for overcoming gemcitabine resistance in bladder cancer treatment. gemcitabine microRNA 1295a Homo sapiens